Press release article from our research archive:
|
|
Lixte Biotechnology Holdings Inc. Review in Progress.
- Article from:
-
M2 Presswire
- Article date:
-
April 24, 2008
|
Copyright informationCOPYRIGHT 2008 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-24 April 2008-MG Strategies: Lixte Biotechnology Holdings Inc. Review in Progress(C)1994-2008 M2 COMMUNICATIONS LTD
RDATE:24032008
MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Investors wanting to know the truth about investing and how to consistently profit from whatever the markets throw our way should sign up to www.maybachfinancial.com for a free trial subscription. Through our numerous partnerships with many of the top investment minds in the world, we provide research on every company making a move in the markets. Investors seeking genuine analyst opinions on their investments for should ...
Related newspaper, magazine, and journal articles:
|
Lixte Biotechnology Holdings Inc. Receives Attention.
M2 Presswire;
April 24, 2008 ;
700+ words
......Financial Edition: Lixte Biotechnology Holdings Inc. Receives Attention...we began tracking Lixte Biotechnology Holdings Inc. (OTC BB: LIXT...Wednesday, April 23, 2008, Lixte Biotechnology Holdings announced today that...
|
|
RealPennies.com: Turning Pennies into dollars: (OTCBB:LIXT) Lixte...
M2 Presswire;
August 8, 2008 ;
700+ words
......realpennies.com/lixt.html Lixte Biotechnology Holdings Announces That Novel...SETAUKET, N.Y., Aug. 8 - Lixte Biotechnology Holdings, Inc. announced recently...Biotechnology Holdings, Inc.: Lixte Biotechnology Holdings, Inc. is a cancer ...
|
|
Lixte Biotechnology Holdings Announces That Novel Compounds Being...
PR Newswire;
August 8, 2008 ;
542 words
......Aug. 8 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc. (BULLETIN BOARD: LIXT) announced...malignant form of brain cancer. About Lixte Biotechnology Holdings, Inc.: Lixte Biotechnology Holdings, Inc. is a cancer therapeutics...
|
|
Lixte Biotechnology Holdings Announces Extension of Its Cooperative...
PR Newswire;
June 25, 2008 ;
700+ words
......PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings (BULLETIN BOARD: LIXT...of Health (NIH) and Lixte Biotechnology Holdings, Inc. extended their...Biotechnology Holdings, Inc.: Lixte Biotechnology Holdings, Inc. is a cancer therapeutics...
|
|
Has added Lixte Biotechnology Holdings, Inc. to their watch list.
M2 Presswire;
February 26, 2008 ;
700+ words
......Financial Group: Has added Lixte Biotechnology Holdings, Inc. to their watch...activity has brought Lixte Biotechnology Holdings, Inc. on our radar...February 26, 2008, Lixte Biotechnology Holdings, Inc. was a flat trader...
|
|
Lixte Biotechnology Holdings Announces New Appointment To Board Of...
PR Newswire;
November 29, 2007 ;
700+ words
......Board of Directors and CEO of Lixte Biotechnology Holdings, Inc. (BULLETIN BOARD: LIXT...with him stated Dr. Kovach. About Lixte Biotechnology Holdings, Inc.: Lixte Biotechnology Holdings, Inc. (Lixte) is a cancer therapeutics...
|
|
Lixte Biotechnology Holdings, Inc. Announces Further Developments...
PR Newswire;
February 26, 2008 ;
700+ words
......Feb. 26 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc. (BULLETIN BOARD: LIXT:OB...serious fungal diseases. About Lixte Biotechnology Holdings, Inc.: Lixte Biotechnology Holdings, Inc. (Lixte) is a cancer therapeutics...
|
|
Lixte Biotechnology Holdings, Inc. Announces Completion of Private...
PR Newswire;
December 18, 2007 ;
700+ words
......PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc. (BULLETIN BOARD...placement. In the placement, Lixte sold 1,000,000 shares...non-accountable expense fee. Lixte also issued to WestPark...exercisable at $0.65 per share. Lixte agreed to file a registration...least 50% of the ...
|
|
Angel works on cleaner chemicals.(News)
The Journal (Newcastle, England);
March 4, 2006 ;
246 words
...Medical research company Angel Biotechnology Holdings has signed a deal with a biological chemical producer...Gordon Sherriff, chief operating officer of Angel Biotechnology Holdings, said: We are very pleased to work with IBC and...
|
See all results.
Or, try our
Advanced Search.
|